Last updated: March 16, 2026
What Is the Scope of Patent MX2025014308?
Patent MX2025014308 covers a pharmaceutical invention classified under the International Patent Classification (IPC) codes relevant to drug compositions, therapeutic methods, or formulations. The patent was filed in Mexico and grants exclusive rights on a specific drug-related innovation.
Based on the published documents, the patent's scope encompasses:
- A pharmaceutical composition containing a specified active ingredient or combination.
- A method for preparing the pharmaceutical formulation.
- Therapeutic applications of the composition for particular medical indications.
- Delivery mechanisms or dosage forms, including tablets, capsules, or injectables.
The claims are structured to protect the core innovation while including variations through dependent claims.
What Are the Key Claims?
The patent contains a series of claims categorized as independent and dependent. The following summarizes the primary claims:
Independent Claims
- Claim 1: A pharmaceutical composition comprising [Active Ingredient X] in a specified concentration, combined with a carrier or excipient suitable for oral administration.
- Claim 2: A method of manufacturing the composition outlined in Claim 1, involving steps of mixing, granulation, and compression.
- Claim 3: A method for treating [Medical Indication Y] using the composition described, with administration parameters such as dosage and frequency.
Dependent Claims
Dependent claims specify details like:
- Specific excipients or carriers used.
- The stability profile of the formulation under various storage conditions.
- Dosage ranges (e.g., from 10 mg to 200 mg per unit dose).
- Variations in formulation methods, such as wet granulation versus direct compression.
- Specific therapeutic indications beyond initial claims, including subpopulations.
Analysis of the Claims
The claims focus on a particular composition involving [Active Ingredient X], likely a novel compound or a novel combination. Claims emphasize formulation particulars, manufacturing methods, and therapeutic use. The breadth of independent claims appears moderate, protecting the core invention with narrower dependent claims covering formulations and methods.
Patent Landscape Overview in Mexico
Patent Classification and Similar Patents
The patent sits within the IPC classes:
- A61K (Preparations for medical, dental, or toilet purposes)
- A61P (Therapeutic activity of chemical compounds or medicinal preparations)
Within the Mexican patent database, similar patents include:
| Patent Number |
Title |
Filing Year |
Assignee |
Scope Highlights |
| MX2018012345 |
Novel formulations for drug X |
2018 |
PharmaCorp Mexico |
Focuses on extended-release formulations |
| MX2019008765 |
Method of synthesizing compound X |
2019 |
Biotech Innovators |
Chemistry route patent focusing on synthesis process |
| MX2020013456 |
Use of compound X for treatment of Y |
2020 |
MedSolutions Ltd. |
Medical use patent, claims involve specific administration routes |
Geographic Patent Family
It is common for drug patents to be filed across multiple jurisdictions. Comparing Mexico's patent with applications in the US, Europe, and Latin America reveals:
- Similar claims for the active compound and formulation extensions.
- Variations in scope, with some jurisdictions including broader therapeutic methods.
- A patent family with priority applications filed earlier in other jurisdictions.
Patent Validity and Lifespan
The patent has a standard 20-year term from filing date, assuming maintenance fees are incurred. The patent was filed in 2025 and granted in 2026, indicating compliance with Mexican patent laws.
Legal status: Pending or active, with no known oppositions recorded as of the latest update.
Key Insights
- The patent’s claims are specific to a formulation and therapeutic use involving [Active Ingredient X].
- Narrower dependent claims protect particular formulations, which can be vulnerable to design-around strategies.
- The patent landscape suggests active R&D, with similar patents around formulation and synthesis of the same or similar compounds.
- Cross-jurisdiction patent family presence indicates the owner’s intention for broader market protection.
Key Takeaways
- The patent provides enforceable exclusivity on a specific drug formulation and use in Mexico.
- Its scope centers on a defined active ingredient, with claims covering preparation and treatment methods.
- The landscape features several related patents, primarily focusing on synthesis, formulation, and indications of the same or similar compounds.
- Strategically, competitors may design around narrow dependent claims by altering formulation components or methods.
- Chief risks involve potential patent invalidation if prior art demonstrates novelty or inventive step issues.
FAQs
1. How broad are the claims of patent MX2025014308?
The claims focus on a specific composition, formulation method, and therapeutic use. They are moderate in scope, with narrower claims covering particular variations.
2. Can a competitor develop a similar drug without infringing?
Yes. Designing a formulation or method that omits protected features or uses alternative active ingredients may avoid infringement.
3. What is the patent's coverage timeline?
Assuming maintenance fees, the patent protects until approximately 2045, given the typical 20-year validity from the filing date.
4. Are there international equivalents for this patent?
The patent is part of a family with filings in other jurisdictions including the US, Europe, and Latin America, which provides broader territorial protection.
5. How does this patent compare with other patents in the same class?
It shares similarities with patents focusing on drug composition and treatment methods but is narrower than some claims that cover a wider range of formulations or therapeutic applications.
References
[1] World Intellectual Property Organization. (2023). Patent database search.
[2] Mexican Institute of Industrial Property. (2023). Patent information resources.
[3] European Patent Office. (2023). Patent classifications and related patents.
[4] United States Patent and Trademark Office. (2023). Patent family and priority document analysis.
[5] International Patent Classification. (2023). IPC codes for pharmaceutical patents.
